drugset / Trial / NCT00005024

Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant Disease

NCT00005024

RandomizedSupportive care

Summary

RATIONALE: Antiemetic drugs such as granisetron may help to prevent nausea and vomiting in patients treated with chemotherapy. PURPOSE: Randomized phase III trial to compare the effectiveness of granisetron with that of a placebo in preventing nausea and vomiting after chemotherapy in patients who have malignant disease.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Granisetron Other / unclassified Oral
Background Carboplatin Small molecule Intravenous
Background Cyclophosphamide Other / unclassified Intravenous
Background Doxorubicin Other / unclassified Intravenous